Target intelligence / Profile preview

RAD17 pseudogene 1 (RAD17P1)

Target
RAD17P1
Molecular classification
Other (pseudogene)
01

Overview

RAD17 pseudogene 1 (RAD17P1) is a non-coding genetic element classified as a pseudogene, meaning it shares sequence similarity with the functional RAD17 gene but lacks the ability to encode an active protein[1][2][3]. RAD17P1 is not known to have biological functions or disease associations, nor does it serve as a therapeutic target. Instead, RAD17P1 arose as a duplication of the RAD17 gene followed by loss of function due to mutations. In contrast, the parent gene, RAD17, encodes a critical enzyme in the DNA damage checkpoint, essential for genomic integrity and implicated in cancer biology[1][2][3]. RAD17P1 is often mentioned as part of gene annotations because the presence of pseudogenes can complicate genetic analyses, but by itself, it does not have a biological or therapeutic role. The entity “RAD17 pseudogene 1” is not a receptor, enzyme, transporter, or any other functional protein target. Structurally, it is a pseudogene, *not* an active gene product nor a therapeutic target; if you are seeking a target for drug discovery or biomarker research, refer to the functional gene RAD17[1][2][3].

Other names
HRAD17P1RAD17 homolog, pseudogene 1

Beyond the preview

Go deeper on RAD17 pseudogene 1 (RAD17P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RAD17 pseudogene 1 (RAD17P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call